World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: PACTR
Last refreshed on: 29 April 2013
Main ID:  PACTR201105000292708
Date of registration: 02/05/2011
Primary sponsor: DR EZEAMA C
Public title: PROPHYLACTIC ERGOMETRIN VERSUS OXYTOCIN IN THIRD STAGE
Scientific title: PROPHYLACTIC ERGOMETRINE VERSUS OXYTOCIN FOR WOMEN IN THE THIRD STAGE OF LABOUR: A DOUBLE-BLIND, RANDOMIZED TRIAL
Date of first enrolment: 2011-06-01
Target sample size: 600
Recruitment status: Not yet recruiting
URL:  HTTP://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?da=true&tno=PACTR201105000292708
Study type:  interventional
Study design:  Parallel: different groups receive different interventions at same time during study,
Randomised,
simple randomization using a randomization table created by a computer software program,
sealed opaque envelopes,
 
Countries of recruitment
South Africa
Contacts
Name: George  Eleje
Address:  NAUTH,NNEWI,NNEWI ONITSHA ROAD,PMB 5025, PMB 5025 NNEWI,ANAMBRA STATE, Nigeria
Telephone: +2348068117444
Email: georgel21@yahoo.com
Affiliation:  Senior Registrar
Name: Theresa  Okoh
Address:  NAUTH,NNEWI,NNEWI ONITSHA ROAD,PMB 5025, PMB 5025 NNEWI,ANAMBRA STATE, Nigeria
Telephone: +2348037250991
Email: tessynkemokoh@yahoo.co.uk
Affiliation:  Matron
Key inclusion & exclusion criteria
Inclusion criteria: Consenting women
Women who had vaginal delivery

Exclusion criteria: Refusal of consent
Women that had Caesarean Section
Women with Antepartum haemorrhage.
Women with Pregnancy induced hypertension, chronic hypertension, eclampsia or cardiac disease in pregnancy.
Women with severe anaemia in pregnancy.



Age minimum: 18 Year
Age maximum: 45 Year
Gender: Female
Health Condition(s) or Problem(s) studied

POST PARTUM HAEMORRHAGE
Intervention(s)
Primary Outcome(s)
1. Measured blood loss b500 mls after intervention. 2. Side effects (Headache, vomiting, increased diastolic hypertension) within 30 minutes of intervention.
Secondary Outcome(s)
1. Blood Transfusion 2. Additional Uterotonic agent after enrolment 3. Manual Removal of Placenta 4. Evacuation of retained products of conception 5. Hysterectomy 6. Maternal Death
Secondary ID(s)
Source(s) of Monetary Support
DR EZEAMA C
Secondary Sponsor(s)
LIFE SPECIALIST HOSPITAL, LTD
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history